Kevin is a Venture Partner and has been with OrbiMed since 2016. Kevin has been active in the life science industry for 20+ years with a focus on drug discovery, translational medicine, and clinical development. Most recently, Kevin was the Senior Vice President of Drug Discovery: Chemical and Molecular Therapeutics at Biogen where he managed global drug discovery and biomarker development as well as the immunology and hematology teams. From 1998-2013, Kevin served as the President, Chief Scientific Officer, Board member, and Co-Founder of Array BioPharma, Inc. While there, he built a fully integrated R&D team that oversaw the invention of over 20 clinical development candidates in the multiple therapeutic areas. Prior to Array, he held senior positions at Amgen Inc. and Pfizer Central Research. Kevin received a B.S. in Chemistry and Biochemistry from State University of New York, Stony Brook, and his Ph.D. in Organic Chemistry from University of Rochester.